In the abstract of ''Canadian Association of Radiologists Radiation Protection Working Group: Automated Patient-Specific Dose RegistriesdWhat Are They and What Are They Good For?'', Bjarnason et al [1] mention ''as low as reasonably achievable'' for diagnostic exams that use ionizing radiation. As low as reasonably achievable combined with the oft used term ''patient-centred'' suggests that the right amount of dose was used to balance the risks associated with ionizing radiation to the benefit associated with an accurate diagnosis of the patient's condition; this requires that we adjust protocols to a patient's age, gender, body size, and clinical indication. This very basic measure of process control is something that most patients would appreciate and probably assume is happening now.
We believe that the best, and perhaps only way to confirm this, is to first calculate the statistical distribution of a dose index received by all patients undergoing a particular type of examination protocol, and confirming that smaller, younger patients or patients with chronic conditions are imaged with a low dose protocol. Using a Radiation Dose Index Monitoring System (RDIM) is the simplest way to track this information and maintain adequate quality control. These systems can also provide accurate up-to-date information on whether there is unjustified variation by protocol across scanners and whether or not, on average, a particular benchmark dose or achievable dose is being acquired over time.
Using an RDIM that tracks patient examinations using a ''cumulative'' dose within a specific modality such as computed tomography (CT) is also the simplest way to identify patients that could be imaged with another modality that does not have the inherent risks associated with ionizing radiation, or with an ''optimized'' or lower dose CT protocol. This topic is related more to the appropriateness of a particular type of examination, or what is referred to in the United Kingdom as ''justification,'' and a patient's previous examination types should be considered a part of the riskbenefit ratio equation. In order to justify an examination that may represent an increased risk to a particular patient, it is incumbent on us to first evaluate whether the examination will yield useful diagnostic information. Repeat exams with no clinically relevant findings should only be conducted if there is scientific evidence that this type of surveillance will lead to an improved patient outcome.
In the United Kingdom, Europe, and Ireland the methods of establishing the dose distribution for a given protocol and comparing them to a benchmark at the local (institutional) or national level has been in place for nearly two decades [2] . The U.S. American College of Radiology proactively established a Dose Index Registry for this purpose in 2011. The U.S. Joint Commission has also instituted radiation dose index monitoring as part of its accreditation standards. And, this quality control is also recommended in Health Canada's Safety Code 35 [3] . Health Canada conducted a manual survey of radiation dose for CT with results due in 2015. Once these data are released, an individual institution will want to determine if their doses are in line with other institutions in Canada; using an RDIM will help them do this. 
